Purchase Summary

In order to access content on the FENIX Marketplace, you must have an account. You will also have access to FENIX Free updates.

The price for access is $599.00.

Account Information Already have an account? Log in here

LEAVE THIS BLANK

Payment Information We accept all major credit cards

By selecting this, I agree to receive emails from fenix.group.

You will be redirected to view the full article after purchasing. You will receive your account and payment information in a confirmation email, and can be viewed at any time in your Account.
RETURN TO HOME
$599
Other, Topics

Happy Holidays from FENIX!

Here is a brief preview of this blast: As we close out 2025, we would like to thank all of our readers for your continued support. We delivered 246 best-in-class cardiometabolic insight blasts to you (basically daily), and next year promises to be even busier! The FENIX Team will be on a content holiday returning on Monday, January 5, 2026, and we’ll be ready to kick off the year with coverage of the JPM conference (January 12-15, 2026). We look forward to providing you with industry-leading insights in 2026!

About The Author

Matthew Maryniak

|
President of Fenix Group International
Matthew has been a thought leader in the high-growth therapeutic areas of diabetes and cardiovascular medicine since 2006, making regular attendance at large and small CV/met scientific meetings and an architect of novel methods for assessing market opportunities. He has over a decade of experience in leading CV/met consulting engagements, is a published author in PM360 and Diabetes Technology & Therapeutics, and has been quoted in The Pink Sheet on anti-thrombotics.